Simultaneous occurrence of Hodgkin’s lymphoma and multiple myeloma: A case report and review of the literature

Oncology Letters

Volumn 11, Issue 6, 2016, Pages 4139-4143

  Huang, Chen ^a   Zhao, Guimin ^a   Wang, Lianjing ^a   Zhang, Huichao ^a   Wu, Xiaolin ^a   Zhang, Mingzeng ^a   Ma, Ruijuan ^a   Wang, Ling ^a   Liu, Yueping ^a   Liu, Lihong ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Disease diagnosis; Hodgkin s lymphoma; Multiple myeloma

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BLEOMYCIN; C REACTIVE PROTEIN; CD15 ANTIGEN; CD163 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; DACARBAZINE; DEXAMETHASONE; GLOBULIN; IMMUNOGLOBULIN A; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; LACTATE DEHYDROGENASE; PIRARUBICIN; PROGRAMMED DEATH 1 RECEPTOR; SYNDECAN 1; THALIDOMIDE; TRANSCRIPTION FACTOR PAX5; VINCRISTINE;

ADULT; BONE MARROW BIOPSY; CASE REPORT; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW BACK PAIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUSSION; PROTEIN BLOOD LEVEL; PROTEIN ELECTROPHORESIS; REVIEW; WHOLE BODY SCINTISCANNING;

EID: 84966839412     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.4503     Document Type: Review

References (31)

1. Townsend W and Linch D: Hodgkin’s lymphoma in adults. Lancet 380: 836-847, 2012.
2. Glaser SL and Hsu JL: Hodgkin’s disease in Asians: Incidence patterns and risk factors in population-based data. Leuk Res 26: 261-269, 2002.
3. Gobbi PG, Ferreri AJ, Ponzoni M and Levis A: Hodgkin lymphoma. Crit Rev Oncol Hematol 85: 216-237, 2013.
4. Klasa RJ, Connors JM, Fairey R, Gascoyne R, Hoskins P, O’Reilly S, Shenkier T, Voss K and Wilson K; British Columbia Cancer Agency (BCCA): Treatment of early stage Hodgkin’s disease: Improved outcome with brief chemotherapy and radiotherapy without staging laparotomy. Annal Oncol 7 (Suppl 3): 21, 1996.
5. Raab MS, Podar K, Breitkreutz I, Richardson PG and Anderson KC: Multiple myeloma. Lancet 374: 324-339, 2009.
6. Palumbo A and Anderson K. Multiple myeloma: N Engl J Med 364: 1046-1060, 2011.
7. Sonneveld P, Schmidt-Wolf IG, van der Holt B, El Jarari L, Bertsch U, Salwender H, Zweegman S, Vellenga E, Broyl A, Blau IW, et al: Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: Results of the randomized phase III HOVON-65/ GMMG-HD4 trial. J Clin Oncol 30: 2946-2955, 2012.
8. Diefenbach C and Advani R: Customized targeted therapy in Hodgkin lymphoma: Hype or hope?. Hematol Oncol Clin North Am 28: 105-122, 2014.
9. Tosi P: Diagnosis and treatment of bone disease in multiple myeloma: Spotlight on spinal involvement. Scientifica (Cairo) 2013: 104546, 2013.
10. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
11. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G and Pileri SA: The EnVision++ system: A new immunohistochemical method for diagnostics and research. Critical comparisonwith the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51: 506-511, 1998.
12. Durie BG, Salmon SE: A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presentingclinical features, response to treatment, and survival. Cancer. 36: 842-854, 1975.
13. Smithers DW: Summary of papers delivered at the Conference on Staging in Hodgkin’s Disease (Ann Arbor). Cancer Res 31: 1869-1870, 1971.
14. Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY, Bi CF, Zuo Z, Wang XQ, Huang J, et al: Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6: 77, 2011.
15. Gherlinzoni F, Cavo M, Pileri S, Rivano MT, Boriani S, Biagini R and Emiliani E: Solitary plasmocytoma of the bone in a case of Hodgkin’s disease. Acta Haematol 76: 178-180, 1986.
16. Weisenberg E, Anastasi J, Adeyanju M, Variakojis D and Vardiman JW: Hodgkin’s disease associated with chronic lymphocytic leukemia. Eight additional cases, including two of the nodular lymphocyte predominant type. Am J Clin Pathol 103: 479-484, 1995.
17. Chan WC, Griem ML, Grozea PN, Freel RJ and Variakojis D: Mycosis fungoides and Hodgkin’s disease occurring in the same patient. Report of three cases. Cancer 44: 1408-1413, 1979.
18. Harris NL: The relationship between Hodgkin’s disease and non-Hodgkin’s lymphoma. Semin Diagn Pathol 9: 304-310, 1992.
19. Loutayf Ranea JJ: Lymph node plasmacytoma as the 2d tumor in a patient with Hodgkin’s disease. Medicina (B Aires) 46: 252, 1986 (In Spanish).
20. Berkessy S, Radványi G, Nagy Z and Takács I: A case of multiple myeloma, associated with terminal plasma cell leukemia following recovery from Hodgkin’s disease. Orv Hetil 129: 1053-1055, 1988 (In Hungarian).
21. Greenberg BB, Stats D and Goldberg M: The simultaneous occurrence of plasma cell multiple myeloma and Hodgkin’s disease. N Y State J Med 50: 305-307, 1950.
22. Gelmann EP and Dennis LH: Plasma-cell dyscrasia after alkylating-agent therapy for Hodgkin’s disease. N Engl J Med 305: 1350, 1981.
23. Hasskarl J, Ihorst G, De Pasquale D, Schröttner P, Zerweck A, Wäsch R and Engelhardt M: Association of multiple myeloma with different neoplasms: Systematic analysis in consecutive patients with myeloma. Leuk Lymphoma 52: 247-259, 2011.
24. Ibarrola de Andrés C, Toscano R, Lahuerta JJ and Martínez-González MA: Simultaneous occurrence of Hodgkin’s disease, nodal Langerhans’ cell histiocytosis and multiple myeloma IgA (kappa). Virchows Arch 434: 259-262, 1999.
25. Lalayanni C, Theodoridou S, Athanasiadou A, Saloum R and Tsatalas C: Simultaneous occurrence of multiple myeloma and Hodgkin’s disease. A case report. Haematologica 85: 772-773, 2000.
26. Sundeen J, Lipford E, Uppenkamp M, Sussman E, Wahl L, Raffeld M and Cossman J: Rearranged antigen receptor genes in Hodgkin’s disease. Blood 70: 96-103, 1987.
27. Bräuninger A, Hansmann ML, Strickler JG, Dummer R, Burg G, Rajewsky K and Küppers R: Identification of common germinal center B-cell precursors in two patients with both Hodgkin’s disease and non-Hodgkin’s lymphoma. N Engl J Med 340: 1239-1247, 1999.
28. Ibbotson RM, Revell PA, Molland EA and Minton MJ: The simultaneous presence of Hodgkin’s disease and myeloma. Postgrad Med J 53: 52-53, 1977.
29. Tilly H, Bastard C, Delastre T, Duval C, Bizet M, Lenormand B, Daucé JP, Monconduit M and Piguet H: Cytogenetic studies in untreated Hodgkin’s disease. Blood 77: 1298-1304, 1991.
30. Lu ZY, Brailly H, Wijdenes J, Bataille R, Rossi JF and Klein B: Measurement of whole body interleukin-6 (IL-6) production: Prediction of the efficacy of anti-IL-6 treatments. Blood 86: 3123-3131, 1995.
31. Seymour JF, Talpaz M, Hagermeister FB, Cabanillas F and Kurzrock R: Clinical correlates of elevated serum levels of interleukin-6 in patients with untreated Hodgkin’s disease. Am J Med 102: 21-28, 1997.